Core Viewpoint - Jiuan Medical experienced a decline of 2.78% in stock price on November 11, with a trading volume of 1.483 billion yuan, indicating market volatility and investor sentiment towards the company [1]. Financing and Margin Trading - On November 11, Jiuan Medical had a financing buy-in amount of 198 million yuan and a financing repayment of 188 million yuan, resulting in a net financing purchase of 9.05 million yuan [1]. - The total margin trading balance for Jiuan Medical reached 1.242 billion yuan as of November 11, with a financing balance of 1.231 billion yuan, accounting for 6.16% of the circulating market value, which is above the 90th percentile of the past year [1]. - In terms of securities lending, Jiuan Medical repaid 4,600 shares and sold 300 shares on November 11, with a remaining short position of 261,100 shares and a short balance of 11.2173 million yuan, also above the 90th percentile of the past year [1]. Company Overview - Jiuan Medical, established on August 22, 1995, and listed on June 10, 2010, is located in Tianjin and specializes in the research, production, and sales of home medical health electronic products [1]. - The revenue composition of Jiuan Medical includes iHealth series products (78.56%), ODM/OEM products (7.72%), internet medical products and services (6.57%), new retail business (5.03%), traditional hardware products (1.46%), and others (0.66%) [1]. Shareholder and Financial Performance - As of October 31, the number of shareholders for Jiuan Medical was 67,500, a decrease of 3.30% from the previous period, while the average circulating shares per person increased by 3.41% to 6,878 shares [2]. - For the period from January to September 2025, Jiuan Medical reported a revenue of 1.069 billion yuan, a year-on-year decrease of 48.89%, while the net profit attributable to shareholders increased by 16.11% to 158.9 million yuan [2]. Dividend and Institutional Holdings - Jiuan Medical has distributed a total of 1.794 billion yuan in dividends since its A-share listing, with 1.39 billion yuan distributed over the past three years [3]. - As of September 30, 2025, among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF held 9.4265 million shares, a decrease of 1.562 million shares from the previous period, while other institutional shareholders also reported reductions in their holdings [3].
九安医疗11月11日获融资买入1.98亿元,融资余额12.31亿元